134 related articles for article (PubMed ID: 38168561)
21. Platelet adherence to cancer cells promotes escape from innate immune surveillance in cancer metastasis.
Okazaki M; Yamaguchi T; Tajima H; Fushida S; Ohta T
Int J Oncol; 2020 Oct; 57(4):980-988. PubMed ID: 32945350
[TBL] [Abstract][Full Text] [Related]
22. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules.
Liu Y; Zhang Y; Ding Y; Zhuang R
Crit Rev Oncol Hematol; 2021 Nov; 167():103502. PubMed ID: 34662726
[TBL] [Abstract][Full Text] [Related]
23. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
24. Targeting self-assembly peptide for inhibiting breast tumor progression and metastasis.
Luo S; Feng J; Xiao L; Guo L; Deng L; Du Z; Xue Y; Song X; Sun X; Zhang Z; Fu Y; Gong T
Biomaterials; 2020 Aug; 249():120055. PubMed ID: 32315863
[TBL] [Abstract][Full Text] [Related]
25. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
Yang W; Liu J; Hou L; Chen Q; Liu Y
Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
Zhao H; Jiang R; Feng Z; Wang X; Zhang C
J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
[TBL] [Abstract][Full Text] [Related]
27. The enhancement of glycolysis regulates pancreatic cancer metastasis.
Yang J; Ren B; Yang G; Wang H; Chen G; You L; Zhang T; Zhao Y
Cell Mol Life Sci; 2020 Jan; 77(2):305-321. PubMed ID: 31432232
[TBL] [Abstract][Full Text] [Related]
28. The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis.
Plantureux L; Mège D; Crescence L; Carminita E; Robert S; Cointe S; Brouilly N; Ezzedine W; Dignat-George F; Dubois C; Panicot-Dubois L
Cancer Res; 2020 Jan; 80(2):291-303. PubMed ID: 31727628
[TBL] [Abstract][Full Text] [Related]
29. Targeted co-delivery of PD-L1 monoclonal antibody and sorafenib to circulating tumor cells via platelet-functionalized nanocarriers.
Da X; Mo J; Li Q; Cao B; Huang J; Lu Y; Lu L; Fan M; Lu H
Biochem Biophys Res Commun; 2023 Sep; 671():335-342. PubMed ID: 37327705
[TBL] [Abstract][Full Text] [Related]
30. The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis.
Shi Q; Ji T; Tang X; Guo W
Cell Oncol (Dordr); 2023 Jun; 46(3):521-532. PubMed ID: 36652166
[TBL] [Abstract][Full Text] [Related]
31. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
Xu Q; Dou C; Liu X; Yang L; Ni C; Wang J; Guo Y; Yang W; Tong X; Huang D
Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387
[TBL] [Abstract][Full Text] [Related]
32. PDGF-BB/PDGFRβ promotes epithelial-mesenchymal transition by affecting PI3K/AKT/mTOR-driven aerobic glycolysis in Wilms' tumor G401 cells.
Guo JQ; Wang CD; Tang HY; Sang BT; Liu X; Yi FP; Wu XM
Cell Biol Int; 2022 Jun; 46(6):907-921. PubMed ID: 35165984
[TBL] [Abstract][Full Text] [Related]
33. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
34. Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.
Li J; Ai Y; Wang L; Bu P; Sharkey CC; Wu Q; Wun B; Roy S; Shen X; King MR
Biomaterials; 2016 Jan; 76():52-65. PubMed ID: 26519648
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies.
Yu L; Guo Y; Chang Z; Zhang D; Zhang S; Pei H; Pang J; Zhao ZJ; Chen Y
Front Oncol; 2021; 11():764119. PubMed ID: 34722319
[TBL] [Abstract][Full Text] [Related]
36. Targeting glycoprotein VI to disrupt platelet-mediated tumor cell extravasation.
Tesfamariam B; Wood SC
Pharmacol Res; 2022 Aug; 182():106301. PubMed ID: 35710063
[TBL] [Abstract][Full Text] [Related]
37. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery.
Zheng Z; Zhang J; Jiang J; He Y; Zhang W; Mo X; Kang X; Xu Q; Wang B; Huang Y
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817393
[TBL] [Abstract][Full Text] [Related]
38. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery.
Chen B; Gao A; Tu B; Wang Y; Yu X; Wang Y; Xiu Y; Wang B; Wan Y; Huang Y
Biomaterials; 2020 Oct; 255():120187. PubMed ID: 32590192
[TBL] [Abstract][Full Text] [Related]
39. Metabolic targeting of platelets to combat thrombosis: dawn of a new paradigm?
Flora GD; Nayak MK; Ghatge M; Chauhan AK
Cardiovasc Res; 2023 Nov; 119(15):2497-2507. PubMed ID: 37706546
[TBL] [Abstract][Full Text] [Related]
40. Codelivery of Shikonin and siTGF-β for enhanced triple negative breast cancer chemo-immunotherapy.
Li J; Zhao M; Liang W; Wu S; Wang Z; Wang D
J Control Release; 2022 Feb; 342():308-320. PubMed ID: 35031387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
